Equillium, Inc. (EQ)
2.20
-0.11
(-4.76%)
USD |
NASDAQ |
Aug 24, 16:00
2.24
+0.04
(+1.82%)
After-Hours: 20:00
Equillium 1 Year Total Returns (Daily) : 15.79% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 15.79% |
| August 21, 2026 | 48.08% |
| August 20, 2026 | 99.12% |
| August 19, 2026 | 94.17% |
| August 18, 2026 | 75.37% |
| August 17, 2026 | 117.5% |
| August 14, 2026 | 140.8% |
| August 13, 2026 | 116.1% |
| August 12, 2026 | 133.4% |
| August 11, 2026 | 151.7% |
| August 10, 2026 | 342.2% |
| August 07, 2026 | 281.6% |
| August 06, 2026 | 232.5% |
| August 05, 2026 | 267.4% |
| August 04, 2026 | 301.2% |
| August 03, 2026 | 209.9% |
| July 31, 2026 | 462.7% |
| July 30, 2026 | 503.2% |
| July 29, 2026 | 471.4% |
| July 28, 2026 | 420.6% |
| July 27, 2026 | 510.9% |
| July 24, 2026 | 578.5% |
| July 23, 2026 | 552.9% |
| July 22, 2026 | 605.9% |
| July 21, 2026 | 535.1% |
| Date | Value |
|---|---|
| July 20, 2026 | 495.0% |
| July 17, 2026 | 515.2% |
| July 16, 2026 | 502.6% |
| July 15, 2026 | 587.7% |
| July 14, 2026 | 652.9% |
| July 13, 2026 | 723.1% |
| July 10, 2026 | 735.7% |
| July 09, 2026 | 778.1% |
| July 08, 2026 | 909.6% |
| July 07, 2026 | 802.8% |
| July 06, 2026 | 762.9% |
| July 02, 2026 | 813.7% |
| July 01, 2026 | 865.1% |
| June 30, 2026 | 915.2% |
| June 29, 2026 | 893.5% |
| June 26, 2026 | 795.7% |
| June 25, 2026 | 783.8% |
| June 24, 2026 | 701.7% |
| June 23, 2026 | 879.3% |
| June 22, 2026 | 774.9% |
| June 18, 2026 | 845.7% |
| June 17, 2026 | 806.1% |
| June 16, 2026 | 708.6% |
| June 15, 2026 | 706.9% |
| June 12, 2026 | 627.0% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 225.2% |
| Fortress Biotech, Inc. | 29.07% |
| Cue Biopharma, Inc. | -6.46% |
| Legend Biotech Corp. | -41.11% |
| Dianthus Therapeutics, Inc. | 353.0% |